Benjamin Tombling

6PUBLICATIONS
16CO-AUTHORS
Biologically active moleculesProteins and peptidesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 03, 2025
TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway.

Alissa D Guarnaccia, Thijs J Hagenbeek, Wendy Lee

|Mar 23, 2021
Increased Valency Improves Inhibitory Activity of Peptides Targeting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9).

Benjamin J Tombling, Carmen Lammi, Carlotta Bollati

|Feb 11, 2021
In Planta Discovery and Chemical Synthesis of Bracelet Cystine Knot Peptides from Rinorea bengalensis.

Tien T Dang, Lai Y Chan, Benjamin J Tombling

|Jan 29, 2021
Engineered EGF-A Peptides with Improved Affinity for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9).

Benjamin J Tombling, Carmen Lammi, Nicole Lawrence

|Dec 28, 2020
Bioactive Cyclization Optimizes the Affinity of a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Peptide Inhibitor.

Benjamin J Tombling, Carmen Lammi, Nicole Lawrence

|Dec 24, 2019
EGF-like and Other Disulfide-rich Microdomains as Therapeutic Scaffolds.

Benjamin J Tombling, Conan K Wang, David J Craik

Pageof 1